ABPI Logo
  • Developing medicines
    • Responding to COVID-19
    • Clinical trials and research
    • Building a thriving environment for medicine discovery
    • UK-EU Future Relationship
    • Life Sciences Industrial Strategy
    • ABPI Medical Representatives Exam
  • Accessing medicines
    • How medicines are priced in the UK
    • Working with the NHS
    • Supply chain
    • Antimicrobial resistance (AMR)
    • Vaccines
    • What is the NICE Methods Review?
    • Rare diseases: Facing three challenges
  • Our ethics
    • ABPI Code of Practice
    • Disclosure UK
    • Appropriate prescribing
    • Patient & public involvement
  • Member representation
    • Events
    • Full membership
    • Working with our members​
    • ABPI Members List
    • Membership benefits
  • Who We Are
  • Media
  • Publications
  • Facts and Figures
  • Contact Us
MY ABPI LOGIN
 
  • The Association of the British Pharmaceutical Industry
  • Developing medicines
  • New medicines & data
  • Medicines Manufacturing Industry Partnership
  • Supply Chain

Supply Chain

The supply chain workstream seeks to deliver capable and connected infrastructure, building understanding of medicines manufacturing supply chains, identifying opportunities to maximise supply and fostering non-competitive sector collaboration.

Page Content

​​The supply chain workstream seeks to deliver capable and connected infrastructure, building understanding of medicines manufacturing supply chains, identifying opportunities to maximise supply and fostering non-competitive sector collaboration.

This includes a successful submission to the Advanced Manufacturing Supply Chain Initiative to develop new digital design and manufacturing processes for medicines. This project has the potential to propel the UK to the forefront of medicinal product design and manufacture through modelling and simulation in medicines development in order to reduce uncertainty and make better, faster and safer design and operating decisions.

Finally, the Knowledge Transfer Network has developed an innovation landscape portal, which provides information on existing medicines manufacturers around the country.

Publications

'Making Pharmaceuticals: Collaborative Research and Translation in Medicines Manufacturing' - Clive Badman, OBE, Making Pharmaceuticals​ Conference Presentation

 

Medicines Manufacturing Industry Partnership

  • MMIP Events
  • Fiscal Environment
  • Regulatory Environment
  • Skills Environment
  • Supply Chain
  • Technology Landscape
  • Medicines Manufacturing UK Landscape
  • MMIP News and Publications

ABPI

The Association of the British Pharmaceutical Industry is a company limited by guarantee registered in England and Wales 
(registered number 09826787) and its registered office is at 7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

© ABPI 2021
  • Twitter Logo
  • LinkedIn
  • YouTube Logo

Devolved Nations

  • Cymru Wales
  • Northern Ireland
  • Scotland

Quick Links

  • ABPI Exam
  • Disclosure UK
  • Frequently Asked Questions
  • Careers
  • Schools
  • Acronym buster

Website Info

  • Terms and conditions
  • Accessibility
  • Cookie Policy

Prescription Medicines Code of Practice Authority (PMCPA)

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

Office of Health Economics (OHE)

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.